Quick translation as the article is in german:
More here
According to an initial investigation, the vaccine from Biontech and its US partner Pfizer apparently largely prevents the transmission of the coronavirus. According to SPIEGEL information, this is the result of a large observational study carried out jointly with the Israeli Ministry of Health.
It was found that the vaccine was 89.4 percent efficient in preventing Sars-CoV-2 infections. For the further course of the pandemic, this message can be decisive in several ways. Around a third of the population in Israel has already been vaccinated.
That is why it was possible for the first time to observe on a broad basis how the vaccine works and influences the pandemic.
Overall, the data from around 1.7 million vaccinated people were apparently included in the study. The results had been eagerly awaited, as the clinical trials for the approval of the corona vaccines only examined how effectively Covid-19 disease is prevented. It was previously unclear whether vaccinated people could still pass the virus on.
Expectations were restrained, and Biontech boss Uğur Şahin had also suspected that his vaccine could prevent 60 percent of infections at most.
The result was actually surprisingly clear: While only 1842 Sars-CoV-2 infections occurred in the group of people who had been vaccinated twice, which corresponds to an incidence rate of 11.5 per 100,000 person-days - i.e. 11.5 infections per 100,000 days that the test persons combined participated in the study - there were 76,797 infections in the control group of the unvaccinated, which corresponds to an incidence rate of 114.4 that is about ten times as high.
The practical data from Israel showed a decrease in infections in ever larger sections of the population. This suggests that vaccinated people not only protect themselves but also others. It is important to note that variant B.1.1.7 was already dominant during the investigation with 81 percent of the cases.
The study is still to be published on a preprint server and in a specialist magazine. For this reason, the detailed data have not yet been commented on by Biontech and Pfizer. However, the almost 22-page paper was already known in Israel.
More here
(S+) Coronavirus: Biontech-Impfstoff stoppt Virusübertragung zu 89,4 Prozent
Überraschender Lichtblick im Kampf gegen Corona: Der Biontech-Impfstoff wirkt nicht nur gegen die Erkrankung, sondern verhindert auch die Infektion. Was das für den Pandemieverlauf bedeutet.
www.spiegel.de